Abstract:Objective To evaluate the feasibility of transarterial prostate embolization for reducing the volume and its technical safety in hormone-induced dogs prostate hyperplasia.Methods Prostate hyperplasia was induced on 12 adult male dogs by administering testosterone propionate for 12 weeks.Then,the dogs were randomly assigned to transarterial prostatic embolization group (n =6) and control group (n =6).Twelve weeks after initiating the hormone treatment,6 animals in transarterial prostatic embolization group underwent prostatic arterial embolization with Embospheres 100-300 μm in diameter.Based on MRI,the volume of prostate was measured for both groups on the three time points:before injection of hormone (BI),before the procedure of prostatic arterial embolization (BP) and 12 weeks after the procedure of prostatic arterial embolization (AP).Finally,the prostates and surrounding tissues were harvested for histopathology study.A statistical software package (SPSS version 19.0) was used for analysis.Measurement data were expressed as x-± s.Samples paired t test was used to compare the prostatic volume between BP and AP.The t test was applied in the intergroup comparison.P ＜ 0.05 was considered to indicate a statistically significant difference.Results The successful rate of BPH model establishment and superselective catheterization were 100％.No serious procedure-related complication was observed.After 12 weeks of hormone administration,the mean volume of prostate was 19.5 ± 2.5 mm3 in embolization group and 19.2 ±3.8 mm3 in control group before prostatic arterial embolization,without statistical difference(t =0.14,P ＞0.05).At 12 weeks after prostatic arterial embolization,the mean volume of prostate was 6.1 ± 1.4 mm3 in embolization group and 17.8 ± 3.5 mm3 in control group with significant statistical difference (t =-7.6,P ＜ 0.05).Compared with pretreatment measurement,the mean volume of prostate decreased by 68.7％ at 12 weeks after prostatic arterial embolization with significant statistical difference (t =10.7,P ＜ 0.05).But there was no statistical difference between the two time points in control group with a 7.3％ mean decrease (t =1.4,P ＞0.05).Histopathology study revealed that embosphere particles had occluded partial arterioles of the prostate in the embolization group of dogs.Near the occluded arterioles,normal gland structure disappeared; while residual gland tissue appeared to be atrophied.In embolization group,there was no gross or microscopic change in the surrounding tissues including bladder,deferent duct and rectum.Extensive prostate glandular hyperplasia was observed in control group.Conclusions Transcatheter arterial embolization is feasible for reducing prostate volume without serious complication in hormone-induced prostate hyperplasia dogs and worthy of further investigation.

Efficacy of trans-rectal ultrasound guided anhydrous Ethanol injection into benign prostate hyperplastic glands

Transurethral ethanol injection therapy of benign prostatic hyperplasia: four-year follow-up

Intracaverous injection of aloprostadil sterile power (prostaglandin E1,caverject) for treatment of erectile dysfunction: a 8-Years experience

Six Novel Minimally Invasive Therapies for Benign Prostatic Hyperplasia

Efficacy and Safety of Endoscopic Ultrasonography-Guided Interventional Treatment for Refractory Malignant Left-Sided Liver Tumors: A Case Series of 26 Patients

Efficacy and Safety of Serenoa repens Extract Among Patients with Benign Prostatic Hyperplasia in China: A Multicenter, Randomized, Double-blind, Placebo-controlled Trial.

Ultrasound-guided transperineal laser ablation for percutaneous treatment of benign prostatic hyperplasia: a new minimally invasive interventional therapy

Comparison of Fluid Absorption Between Transurethral Enucleation and Transurethral Resection for Benign Prostate Hyperplasia

Comparison of irrigating solution absorption between transurethral resection and transurethral vaporization for benign prostatic hyperplasia

Transarterial Prostatic Embolization: Initial Experience in Hormone-Induced Benign Prostatic Hyperplasia in Dogs

Clinical Investigation of RPH Combined with Hemorrhoidlysant Injection in the Treatment of Hemorrhoids for 80 Cases

Efficacy and Safety of Bipolar Plasma Vaporization of the Prostate with "Button-Type" Electrode Compared with Transurethral Resection of Prostate for Benign Prostatic Hyperplasia.

Transurethral Vapor Enucleation and Resection of the Prostate with Plasma Vaporization Button Electrode for the Treatment of Benign Prostatic Hyperplasia: A Feasibility Study

A two-week, double-blind, placebo-controlled trial of Viola odorata, Echium amoenum and Physalis alkekengi mixture in symptomatic benign prostate hyperplasia (BPH) men

Efficacy and safety of Water Vapor Thermal Therapy in the treatment of benign prostate hyperplasia: a systematic review and single-arm Meta-analysis

Prostate Artery Embolization Using N-Butyl Cyanoacrylate Glue for Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia: A Valid Alternative to Microparticles?

Establishment and Short-Term Efficacy of Ultrasound-Guided 125I Seed Interstitial Brachytherapy for Prostatic Carcinoma

Experimental research of percutaneous ethanol therapy with different concentration injections on hepatic vx2 tumor of rabbits

Transperineal ultrasound guided ~(125)I seed implantation combined with endocrinotherapy for stage T_1-T_2 prostate cancer

Safety and Efficacy of Intra‐Prostatic Injection of Betamethasone for Refractory Chronic Nonbacterial Prostatitis: A Prospective Cohort Clinical Study

One-year Effect of Ultrasound Guided Transurethral Balloon Dilation of Prostate for the Treatment of Benign Prostatic Hyperplasia